PYY, peptide YY, 5697

N. diseases: 88; N. variants: 14
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0020175
Disease: Hunger
Hunger
0.100 Biomarker phenotype BEFREE Furthermore, circulating levels of some orexigenic (ghrelin) and anorexigenic (glucagon-like peptide 1 and peptide YY) peptides were measured after a meal completely consumed (lunch), together with the evaluation of hunger and satiety and assessment of resting energy expenditure (REE) through indirect computerized calorimetry. 29530622 2018
CUI: C0020175
Disease: Hunger
Hunger
0.100 AlteredExpression phenotype BEFREE Basal hunger and average hunger and desire to eat were significantly increased at 1 and 2 yr. Basal fullness was significantly increased at W4, and average ratings were reduced at 1 yr. Average AG and PYY were significantly increased, and insulin was reduced, at all time points compared with B. 29360396 2018
CUI: C0020175
Disease: Hunger
Hunger
0.100 Biomarker phenotype BEFREE To investigate the association between postprandial plasma concentrations of amino acids and the anorexigenic hormones glucagon-like peptide-1 (GLP-1) and peptide tyrosine tyrosine (PYY), the orexigenic hormone ghrelin, and satiety and hunger in post-RYGB subjects. 29937240 2018
CUI: C0020175
Disease: Hunger
Hunger
0.100 Biomarker phenotype BEFREE Blood samples were analyzed for BHB, glucose, insulin, ghrelin, glucagon-like peptide 1 (GLP-1), and peptide tyrosine tyrosine (PYY), and a three-measure visual analogue scale was used to measure hunger, fullness, and desire to eat. 29105987 2018
CUI: C0020175
Disease: Hunger
Hunger
0.100 Biomarker phenotype BEFREE This study comes from a series of nested studies examining ingestive behaviors in bulimic syndromes and specifically evaluated the satiety peptide YY (PYY) and the hunger peptide ghrelin in women with PD (n = 25), bulimia nervosa-purging (BNp) (n = 26), and controls (n = 26). 29219202 2018
CUI: C0020175
Disease: Hunger
Hunger
0.100 Biomarker phenotype BEFREE Following the liquid meal, area under the curve (AUC) values for hunger and ghrelin were greater and AUC values for peptide YY lower in the PM than in the AM condition. 29235554 2018
CUI: C0020175
Disease: Hunger
Hunger
0.100 Biomarker phenotype BEFREE Compared with HCs, in patients with AN at Wk0, baseline ghrelin, PYY, fullness, bloating and anxiety were higher, and hunger less, and in response to the meal, ghrelin, bloating and anxiety were greater, and hunger less (all <i>p</i> < 0.05). 30597915 2018
CUI: C0020175
Disease: Hunger
Hunger
0.100 AlteredExpression phenotype BEFREE To investigate differences in ad libitum food intake, feelings of hunger and satiety and the systemic levels of cholecystokinin (CCK), glucagon-like peptide-1 (GLP-1), peptide YY (PYY), glucose and insulin after intraduodenal, intrajejunal and intraileal protein infusion. 27811949 2017
CUI: C0020175
Disease: Hunger
Hunger
0.100 AlteredExpression phenotype BEFREE After three consecutive nights of sleep restriction, fasting peptide YY levels and fullness were significantly decreased (p = 0.011), whereas hunger and prospective food consumption were significantly increased, compared to those under the 7-h sleep condition. 28071649 2017
CUI: C0020175
Disease: Hunger
Hunger
0.100 Biomarker phenotype BEFREE It was hypothesized that lower meal frequency in a reduced-energy regimen leading to greater body weight reduction and reduced hunger would be associated with decreased plasma concentrations of GIHs: gastric inhibitory peptide (GIP), glucagon-like peptide-1(GLP-1), peptide YY(PYY), pancreatic polypeptide (PP) and leptin and increased plasma concentration of ghrelin. 28369078 2017
CUI: C0020175
Disease: Hunger
Hunger
0.100 AlteredExpression phenotype BEFREE Blood was sampled for GLP-1, and PYY levels and hunger ratings were assessed before and ~75 min after drink consumption. 29403396 2017
CUI: C0020175
Disease: Hunger
Hunger
0.100 Biomarker phenotype BEFREE Diet-induced weight loss (WL) leads to increased hunger and reduced fullness feelings, increased ghrelin and reduced satiety peptides concentration (glucagon-like peptide-1 (GLP-1), cholecystokinin (CCK) and peptide YY (PYY)). 28439092 2017
CUI: C0020175
Disease: Hunger
Hunger
0.100 Biomarker phenotype BEFREE These findings support a dose-response relationship between exercise intensity and total PYY, though the effects on total GLP-1 and hunger perceptions seem unclear. 27721013 2017
CUI: C0020175
Disease: Hunger
Hunger
0.100 Biomarker phenotype BEFREE Ad libitum energy intake from a standardized breakfast and plasma changes in hunger-/satiety-associated hormones PYY, GLP-1, ghrelin and serotonin were determined after blood drawings. 28834253 2017
CUI: C0020175
Disease: Hunger
Hunger
0.100 AlteredExpression phenotype BEFREE Peptide YY (PYY), glucagon-like peptide 1 and ghrelin levels, as well as feelings of hunger and satiety, were determined pre- and postprandially in 62 women and 41 men (age 31+/-14 years; body mass index 25.0+/-3.1 kg/m(2)). 18957934 2008